RT Journal Article
SR Electronic
T1 Reversible impairment of renal function associated with enalapril in a diabetic patient
JF Canadian Medical Association Journal
JO CMAJ
FD Canadian Medical Association
SP 1279
OP 1281
VO 159
IS 10
A1 M. M. Albareda
A1 R. Corcoy
YR 1998
UL http://www.cmaj.ca/content/159/10/1279.abstract
AB Acute renal failure and hyperkalemia due to angiotensin-converting enzyme inhibitors have been described in diabetic patients with other predisposing conditions. The case reported here involves a patient with type 1 diabetes mellitus, microalbuminuria and normal renal function who was treated with enalapril. Two years after initiation of this therapy, at a time when glycemic control was poor, he presented with symptomatic hyperkalemia and impaired renal function accompanied by hyporeninemic hypoaldosteronism. This case illustrates that reversible impairment of renal function and hyperkalemia can present after 2 years of treatment with angiotensin-converting enzyme inhibitors in patients with precipitating factors.